Abstract

Introduction

Anti-neoplastic therapy improves the prognosis for advanced cancer, albeit it is not curative. An ethical dilemma that often arises during patients’ first appointment with the oncologist is to give them only the prognostic information they can tolerate, even at the cost of compromising preference-based decision-making, versus giving them full information to force prompt prognostic awareness, at the risk of causing psychological harm.

Methods

We recruited 550 participants with advanced cancer. After the appointment, patients and clinicians completed several questionnaires about preferences, expectations, prognostic awareness, hope, psychological symptoms, and other treatment-related aspects. The aim was to characterize the prevalence, explanatory factors, and consequences of inaccurate prognostic awareness and interest in therapy.

Results

Inaccurate prognostic awareness affected 74%, conditioned by the administration of vague information without alluding to death (odds ratio [OR] 2.54; 95% CI, 1.47-4.37, adjusted P = .006). A full 68% agreed to low-efficacy therapies. Ethical and psychological factors oriented first-line decision-making, in a trade-off in which some lose quality of life and mood, for others to gain autonomy. Imprecise prognostic awareness was associated with greater interest in low-efficacy treatments (OR 2.27; 95% CI, 1.31-3.84; adjusted P = .017), whereas realistic understanding increased anxiety (OR 1.63; 95% CI, 1.01-2.65; adjusted P = 0.038), depression (OR 1.96; 95% CI, 1.23-3.11; adjusted P = .020), and diminished quality of life (OR 0.47; 95% CI, 0.29-0.75; adjusted P = .011).

Conclusion

In the age of immunotherapy and targeted therapies, many appear not to understand that antineoplastic therapy is not curative. Within the mix of inputs that comprise inaccurate prognostic awareness, many psychosocial factors are as relevant as the physicians’ disclosure of information. Thus, the desire for better decision-making can actually harm the patient.

Details

Title
Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the NEOetic Study
Author
Carmona-Bayonas, Alberto 1   VIAFID ORCID Logo  ; Rodriguez-Gonzalez, Adán 2   VIAFID ORCID Logo  ; García-García, Teresa 3   VIAFID ORCID Logo  ; Velasco-Durantez, Verónica 4   VIAFID ORCID Logo  ; Raquel Hernández-San Gil 5   VIAFID ORCID Logo  ; Cruz-Castellanos, Patricia 6   VIAFID ORCID Logo  ; Fernandez-Montes, Ana 7   VIAFID ORCID Logo  ; Castillo-Trujillo, Alfredo 2   VIAFID ORCID Logo  ; Ballester, Inmaculada 1   VIAFID ORCID Logo  ; Rogado, Jacobo 8   VIAFID ORCID Logo  ; Calderon, Caterina 9   VIAFID ORCID Logo  ; Jimenez-Fonseca, Paula 2   VIAFID ORCID Logo 

 Department of Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, UMU, IMIB , Murcia , Spain 
 Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Faculty of Medicine, University of Oviedo , Oviedo , Spain 
 Department of Medical Oncology, Hospital General Universitario Santa Lucia , Cartagena , Spain 
 Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Oviedo, Faculty of Medicine, University of Valladolid , Valladolid , Spain 
 Department of Medical Oncology, Hospital Universitario de Canarias , Tenerife , Spain 
 Department of Medical Oncology, Hospital General Universitario de Ciudad Real , Ciudad Real , Spain 
 Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense , Orense , Spain 
 Department of Medical Oncology, Hospital Universitario Infanta Leonor , Madrid , Spain 
 Department of Clinical Psychology and Psychobiology, Faculty of Psychology. University of Barcelona , Spain 
Pages
986-995
Publication year
2023
Publication date
Nov 2023
Publisher
Oxford University Press
ISSN
10837159
e-ISSN
1549490X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3191876211
Copyright
© The Author(s) 2023. Published by Oxford University Press. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.